Cleared Special

K000079 - NIKOPAD ELECTROSURGICAL GROUNDING PAD, MODEL 4777M (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2000
Decision
24d
Days
Class 2
Risk

K000079 is an FDA 510(k) clearance for the NIKOPAD ELECTROSURGICAL GROUNDING PAD, MODEL 4777M. Classified as Apparatus, Electrosurgical (product code HAM), Class II - Special Controls.

Submitted by Nikomed U.S.A., Inc. (Stillwater, US). The FDA issued a Cleared decision on February 4, 2000 after a review of 24 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Nikomed U.S.A., Inc. devices

Submission Details

510(k) Number K000079 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 11, 2000
Decision Date February 04, 2000
Days to Decision 24 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
90d faster than avg
Panel avg: 114d · This submission: 24d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code HAM Apparatus, Electrosurgical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.